Lobbying Filing Details

Total Spending

$1,200,000

Activities

2

Lobbyists

5

Gov't Entities

8

Filing Information
Filing UUID:
0b57f370-56a5-4f64-a750-d955711a9421
Type:
Q1 - 1st Quarter - Report
Period:
2015 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:
April 19, 2015 at 9:54 PM
Income:
$0
Expenses:
$1,200,000
Expense Method:
Method A - Reporting amounts using LDA definitions only
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Debra S. Barrett, Senior Vice President for Global Government Affairs and Public Policy
Registrant
TEVA PHARMACEUTICALS USA, INC.
Parsippany, New Jersey
Client
TEVA PHARMACEUTICALS USA INC
New Jersey, United States of America
Lobbying Activities (2)
Activity 1
Pharmacy

Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2016 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; HR 406, Combination Drug Development Incentive Act of 2015; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Drug pricing proposals and issues.

Foreign Entity Issues: Teva Pharmaceutical Industries Ltd., as the indirect parent of Teva Pharmaceuticals USA, Inc., has an interest in the issues listed.

Lobbyists (5)
  • DEBRA BARRETT
  • ROBERT FALB
  • TERRI STEWART
  • GRANT ERDEL
  • SUSIE AHN
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • U.S. Trade Representative (USTR)
  • Food & Drug Administration (FDA)
Activity 2
Trade (domestic/foreign)

Trans-Pacific Partnership Trade Agreement; Trans-Atlantic Trade & Investment Partnership Agreement.

Foreign Entity Issues: Teva Pharmaceutical Industries Ltd., as the indirect parent of Teva Pharmaceuticals USA, Inc., has an interest in the issues listed.

Lobbyists (3)
  • DEBRA BARRETT
  • TERRI STEWART
  • GRANT ERDEL
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • U.S. Trade Representative (USTR)
  • Food & Drug Administration (FDA)

Source: LDA.gov, data retrieved November 17, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.